WP
NVAX icon

WealthPLAN Partners’s Novavax NVAX Stock Holding History

WealthPLAN Partners’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-25
Closed -$186 – 852
2023
Q2 		$186 Hold
25
– – ﹤0.01% 1214
2023
Q1 		$173 Buy
+25
New +$230 ﹤0.01% 1280
2017
Q2 		– Sell
-25
Closed -$515 – 338
2017
Q1 		$515 Buy
+25
New +$688 ﹤0.01% 444
2016
Q3 		$12K Buy
300
+25
+9% +$3.23K ﹤0.01% 568
2016
Q2 		$21.8K Buy
+275
New +$31.5K ﹤0.01% 1359

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

WealthPLAN Partners's NVAX Position: Q3 2023 in Review

WealthPLAN Partners sold out of Novavax (NVAX) in Q3 2023, closing a stake of 25 shares — an estimated $186 sold.

WealthPLAN Partners first reported a position in NVAX in Q2 2016 and held it in 5 quarters. The position peaked at $21.8K in Q2 2016. 225 funds tracked by Wall St. Rank hold NVAX as of Q3 2023.

  • WealthPLAN Partners reported no remaining Novavax position as of Q3 2023 after selling out during the quarter.
  • WealthPLAN Partners sold 25 Novavax shares in Q3 2023, an estimated $186.
  • WealthPLAN Partners first reported a position in Novavax in Q2 2016 and held it in 5 quarters.
  • WealthPLAN Partners's Novavax position peaked at $21.8K in Q2 2016.
  • 225 funds tracked by Wall St. Rank held Novavax as of Q3 2023.

Based on WealthPLAN Partners's 13F filing for Q3 2023, filed 2 Nov 2023.